Acadian Asset Management LLC G1 Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$2.2 - $4.98 $1.09 Million - $2.46 Million	494,496 Added 114.02%	928,205 $2.11 Million
Q1 2024 May 10, 2024	BUY	$2.1 - $4.83 $788,243 - $1.81 Million	375,354 Added 643.23%	433,709 $1.87 Million
Q4 2023 Feb 13, 2024	SELL	$1.12 - $3.73 $82,017 - $273,147	-73,230 Reduced 55.65%	58,355 $177,000
Q3 2023 Nov 13, 2023	BUY	$1.22 - $2.67 $160,533 - $351,331	131,585 New	131,585 $189,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $158,165 - $411,412	30,475 New	30,475 $165,000
Q2 2020 Aug 12, 2020	SELL	$9.57 - $24.37 $56,233 - $143,198	-5,876 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$9.07 - $26.32 $53,295 - $154,656	5,876 New	5,876 $65,000
Q2 2019 Aug 08, 2019	SELL	$16.03 - $31.1 $294,487 - $571,338	-18,371 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$14.4 - $21.45 $264,542 - $394,057	18,371 New	18,371 $305,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.